NasdaqGS - Nasdaq Real Time Price • USD
Compare
As of 1:38 PM EDT. Market Open.
Line
Candle
Baseline
Mountain
Bar
Loading Chart for ARAY
9/21 12:03 PM
DELL
Date | |
Close | |
Open | |
High | |
Low | |
Volume |
- Previous Close
1.7400 - Open
1.7500 - Bid 1.7800 x 100
- Ask 1.7900 x 100
- Day's Range
1.7450 - 1.7900 - 52 Week Range
1.4600 - 4.3000 - Volume
190,070 - Avg. Volume
673,645 - Market Cap (intraday)
176.665M - Beta (5Y Monthly) 1.44
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2200 - Earnings Date Aug 7, 2024 - Aug 12, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
6.00
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
1,024
Full Time Employees
June 30
Fiscal Year Ends
Healthcare
Sector
Medical Devices
Industry
More about Accuray Incorporated
Recent News: ARAY
All SEC Filings
Corporate Changes & Voting Matters
Periodic Financial Reports
Proxy Statements
Tender Offer/Acquisition Reports
Offering Registrations
Performance Overview: ARAY
Trailing total returns as of 6/20/2024, which may include dividends or other distributions. Benchmark is
YTD Return
ARAY
37.10%
S&P 500
14.41%
1-Year Return
ARAY
54.00%
S&P 500
23.76%
3-Year Return
ARAY
58.51%
S&P 500
30.98%
5-Year Return
ARAY
53.40%
S&P 500
86.48%
Compare To: ARAY
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
1.7801
+2.30%
Mkt Cap 176.665M
Industry Medical Devices
1.3325
-2.02%
Mkt Cap 46.163M
Industry Medical Devices
10.34
-0.39%
Mkt Cap 1.446B
Industry Medical Devices
1.6150
-0.92%
Mkt Cap 32.458M
Industry Medical Devices
12.61
-2.02%
Mkt Cap 473.244M
Industry Medical Devices
66.99
-0.73%
Mkt Cap 2.063B
Industry Medical Devices
0.8398
+11.53%
Mkt Cap 45.607M
Industry Medical Devices
5.11
-0.97%
Mkt Cap 83.767M
Industry Medical Devices
0.8600
-7.03%
Mkt Cap 8.111M
Industry Medical Devices
10.63
-10.90%
Mkt Cap 716.616M
Industry Medical Devices
1.1200
0.00%
Mkt Cap 21.106M
Industry Medical Devices
Statistics: ARAY
Valuation Measures
As of 6/18/2024
Market Cap
172.68M
Enterprise Value
319.22M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.39
Price/Book (mrq)
4.20
Enterprise Value/Revenue
0.74
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-4.99%
Return on Assets (ttm)
-0.56%
Return on Equity (ttm)
-44.87%
Revenue (ttm)
430.55M
Net Income Avi to Common (ttm)
-21.49M
Diluted EPS (ttm)
-0.2200
Balance Sheet and Cash Flow
Total Cash (mrq)
116.37M
Total Debt/Equity (mrq)
289.67%
Levered Free Cash Flow (ttm)
12.73M
Research Analysis: ARAY
People Also Watch
ANGO AngioDynamics, Inc.
5.81
+2.83%
ATEC Alphatec Holdings, Inc.
10.34
-0.39%
ATRC AtriCure, Inc.
24.23
+14.29%
STXS Stereotaxis, Inc.
1.8300
-0.54%
CUTR Cutera, Inc.
1.6150
-0.92%
AXDX Accelerate Diagnostics, Inc.
1.2700
+9.48%
ECOR electroCore, Inc.
6.11
+5.91%
VRAY ViewRay, Inc.
0.0250
0.00%
CNMD CONMED Corporation
66.99
-0.73%
VNDA Vanda Pharmaceuticals Inc.
6.02
-5.12%
BEAT HeartBeam, Inc.
2.2500
-0.88%
AXGN AxoGen, Inc.
7.02
-1.82%
ALIM Alimera Sciences, Inc.
3.0500
0.00%
BCOV Brightcove Inc.
1.9700
-1.50%
AFMD Affimed N.V.
5.87
-3.06%
OFIX Orthofix Medical Inc.
12.61
-2.02%